Breaking news

Anthropic’s Pricing Policy Shakeup Spurs Debate In The AI Ecosystem

Anthropic introduced a revised pricing model for its Claude API that charges separately for third-party tools, prompting criticism from developers. Peter Steinberger, creator of OpenClaw and an engineer at OpenAI, said the changes create challenges for open-source integrations.

The discussion intensified after Steinberger described the issue on X following a temporary suspension of his account, which was later reversed.

Anthropic’s New Pricing Strategy And Its Implications

Anthropic now applies consumption-based pricing for third-party harnesses such as OpenClaw through the Claude API. The model reflects higher computational costs linked to continuous reasoning loops and integrations with external tools.

Developers criticized the approach, referring to it as a “claw tax,” and noted that the changes coincided with the rollout of Anthropic’s own features in its Cowork agent. The timing raised concerns about reduced support for open-source integrations.

A Temporary Suspension Sparks Industry Conversation

Peter Steinberger’s account on X was temporarily suspended due to activity flagged as suspicious before being restored. An Anthropic engineer later clarified that the company does not ban users for using OpenClaw. The incident drew attention across the developer community and accelerated discussion around platform policies and access. Rapid reversal of the suspension highlighted sensitivity to public scrutiny.

Balancing Competing Interests In A Rapidly Evolving Market

The episode intensified debate over how AI companies balance pricing models with open-source ecosystems. Steinberger said, “One welcomed me, one sent legal threats,” comparing approaches across companies. His role in the OpenClaw Foundation, alongside work at OpenAI, reflects increasing overlap between open-source development and commercial AI strategies.

Looking Ahead

Ongoing discussions focus on how pricing policies affect developer adoption and integration across AI platforms. Market participants continue to assess trade-offs between monetization models and ecosystem openness. Future changes in API pricing and platform policies are likely to influence competition and developer behavior across the AI sector.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

The Future Forbes Realty Global Properties
eCredo
Uol
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter